Mark N. Fluchel, MD

Assistant Professor, Division of Pediatric Hematology and Oncology

Mark N. Fluchel, MD, is an assistant professor of pediatrics in the Division of Pediatric Hematology and Oncology at the University of Utah's School of Medicine. He is also an attending physician at Primary Children's Hospital and a Huntsman Cancer Institute (HCI) investigator.

Fluchel's research focuses on how geography affects the morbidity, mortality, and burden of care in pediatric oncology patients. His goal is to develop better ways to serve patients from rural, immigrant, and underserved communities. Fluchel's research also includes studies designed to help physicians better understand two types of histiocytic disorders (disorders involving an abnormal increase in immune cells): Langerhans Cell Histiocytosis (LCH) and Hemophagocytic Lymphohistiocytosis (HLH). His study uses the Utah Population Database to identify familial associations.

Currently a Pediatric Clinical Translational (PCAT) scholar, Fluchel was recently awarded a Translational Comparative Effectivess Research (T-CER) NIH Institutional Career Enhancement Award for his research of different cancer outcomes. He completed a fellowship in pediatric hematology/oncology at the Children's Hospital of Philadelphia in Pennsylvania. His residency and internship were completed at Seattle Children's Hospital in Washington. Fluchel received his medical degree from Vanderbilt University in Nashville, Tennessee.